Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
Authors:
- Veronica VeschiVeronica Veschi
- Alice TurdoATAlice Turdo
- Chiara ModicaCMChiara Modica
- Francesco VeronaFVFrancesco Verona
- Simone Di FrancoSimone Di Franco
- Miriam GaggianesiMiriam Gaggianesi
- Elena TirròETElena Tirrò
- Sebastiano Di BellaSBSebastiano Di Bella
- Vincenzo Davide PantinaVPVincenzo Davide Pantina
- Gaetana PorcelliGPGaetana Porcelli
Open Access
- 11 March 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-17
Abstract
Thyroid carcinoma (TC) is the most common malignancy of endocrine organs. The cell subpopulation in the lineage hierarchy that serves as cell of origin for the different TC histotypes is unknown. Human embryonic stem cells (hESCs) with appropriate in vitro stimulation undergo sequential differentiation into thyroid progenitor cells (TPCs-day 22), which maturate into thyrocytes (day 30). Here, we create follicular cell-derived TCs of all the different histotypes based on specific genomic alterations delivered by CRISPR-Cas9 in hESC-derived TPCs. Specifically, TPCs harboring BRAFV600E or NRASQ61R mutations generate papillary or follicular TC, respectively, whereas addition of TP53R248Q generate undifferentiated TCs. Of note, TCs arise by engineering TPCs, whereas mature thyrocytes have a very limited tumorigenic capacity. The same mutations result in teratocarcinomas when delivered in early differentiating hESCs. Tissue Inhibitor of Metalloproteinase 1 (TIMP1)/Matrix metallopeptidase 9 (MMP9)/Cluster of differentiation 44 (CD44) ternary complex, in cooperation with Kisspeptin receptor (KISS1R), is involved in TC initiation and progression. Increasing radioiodine uptake, KISS1R and TIMP1 targeting may represent a therapeutic adjuvant option for undifferentiated TCs.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC IG (21445))
This publication has 58 references indexed in Scilit:
- Molecular pathogenesis and mechanisms of thyroid cancerNature Reviews Cancer, 2013
- Kisspeptin/KISS1R System in Breast CancerJournal of Cancer, 2013
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid LeukemiaScience Translational Medicine, 2012
- Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem CellsCell Stem Cell, 2012
- RETRACTED: MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cellsCellular Signalling, 2012
- Molecular genetics and diagnosis of thyroid cancerNature Reviews Endocrinology, 2011
- Thyroid cancer stem cellsNature Reviews Endocrinology, 2011
- Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem CellsCancer Research, 2010
- The KISS1 metastasis suppressor: A good night kiss for disseminated cancer cellsEuropean Journal of Cancer, 2010
- TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survivalThe International Journal of Biochemistry & Cell Biology, 2009